These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2862464)

  • 21. Hyaline membrane disease treated with bovine surfactant.
    Smyth JA; Metcalfe IL; Duffty P; Possmayer F; Bryan MH; Enhorning G
    Pediatrics; 1983 Jun; 71(6):913-7. PubMed ID: 6687937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surfactant replacement in spontaneously breathing babies with hyaline membrane disease--a pilot study.
    Victorin LH; Deverajan LV; Curstedt T; Robertson B
    Biol Neonate; 1990; 58(3):121-6. PubMed ID: 2279046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods.
    Chotigeat U; Promwong N; Kanjanapattanakul W; Khorana M; Sangtawesin V; Horpaopan S
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S109-14. PubMed ID: 19253505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study of treatment of hyaline membrane disease with pulmonary surfactant replacement in premature infant].
    Ji SP; Zhang XL; Ma WX; Sun YP; Li XH; Yu JH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Apr; 19(4):248. PubMed ID: 17448287
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of severe hyaline membrane disease with a single-dose of natural exogenous surfactant of porcine origin. A randomized trial: immediate effects and outcome at 28 days of life].
    Walti H; Relier JP; Huon C; Monset-Couchard M; Scemama M; De Gamarra E; Moriette G; Curstedt T; Robertson B
    Arch Fr Pediatr; 1990 May; 47(5):329-34. PubMed ID: 2196030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surfactant replacement therapy. Innovative care for the premature infant.
    Miller EP; Armstrong CL
    J Obstet Gynecol Neonatal Nurs; 1990; 19(1):14-7. PubMed ID: 2299437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of two strategies for surfactant prophylaxis in very premature infants: a multicenter randomized trial.
    Kendig JW; Ryan RM; Sinkin RA; Maniscalco WM; Notter RH; Guillet R; Cox C; Dweck HS; Horgan MJ; Reubens LJ; Risemberg H; Phelps DL
    Pediatrics; 1998 Jun; 101(6):1006-12. PubMed ID: 9606227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dry artificial lung surfactant and its effect on very premature babies.
    Morley CJ; Bangham AD; Miller N; Davis JA
    Lancet; 1981 Jan; 1(8211):64-8. PubMed ID: 6109119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaline membrane disease (HMD) therapy in Latin America: impact of exogenous surfactant administration on newborn survival, morbidity and use of resources.
    Rossello JD; Hayward PE; Martell M; Del Barco M; Margotto P; Grandzoto J; Bastida J; Peña J; Villanueva D
    J Perinat Med; 1997; 25(3):280-7. PubMed ID: 9288665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease.
    Vidyasagar D; Maeta H; Raju TN; John E; Bhat R; Go M; Dahiya U; Roberson Y; Yamin A; Narula A
    Pediatrics; 1985 Jun; 75(6):1132-42. PubMed ID: 3846883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exogenous surfactant replacement therapy of hyaline membrane disease in premature infants.
    Namgung R; Lee C; Suh JS; Park KI; Han DG
    Yonsei Med J; 1989 Dec; 30(4):355-66. PubMed ID: 2697112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Factors increasing susceptibility to neonatal hyaline membrane syndrome and its prevention. I. Deficiency of surfactant and glucocorticoid treatment].
    Uszyńska-Folejewska R; Uszyński M
    Pediatr Pol; 1977 Dec; 52(12):1413-7. PubMed ID: 343058
    [No Abstract]   [Full Text] [Related]  

  • 33. Surfactant replacement therapy in utero for prevention of hyaline membrane disease in the preterm baboon.
    Galan HL; Cipriani C; Coalson JJ; Bean JD; Collier G; Kuehl TJ
    Am J Obstet Gynecol; 1993 Oct; 169(4):817-24. PubMed ID: 8238135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Respiratory compliance in premature babies treated with artificial surfactant (ALEC).
    Morley CJ; Greenough A
    Arch Dis Child; 1991 Apr; 66(4):467-71. PubMed ID: 2031602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exogenous surfactant therapy in hyaline membrane disease.
    Gitlin JD; Parad R; Taeusch HW
    Semin Perinatol; 1984 Oct; 8(4):272-82. PubMed ID: 6387924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of surfactant therapy on the oxygen treatment of premature infants with HMD].
    Iarŭkova N
    Akush Ginekol (Sofiia); 1998; 37(1):3-5. PubMed ID: 9770786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Administration of surfactant in hyaline membrane disease].
    Valls i Soler A
    An Esp Pediatr; 1987 Sep; 27(3):147-51. PubMed ID: 3322119
    [No Abstract]   [Full Text] [Related]  

  • 38. Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies. Ten Centre Study Group.
    Br Med J (Clin Res Ed); 1987 Apr; 294(6578):991-6. PubMed ID: 2890398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The introduction of surfactant replacement therapy into South Africa.
    Davies VA; Rothberg AD; Ballot DE
    S Afr Med J; 1995 Jul; 85(7):637-40. PubMed ID: 7482078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.